SCHEMBL7811032

SCHEMBL7811032

CCC(C)Oc1ccc2c(c1)n[c]n2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.36
CYSLTR1 Q9Y271 1/20 0.36
FGFR1 P11362 1/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 2/20 0.35
BRD4 O60885 5/20 0.34
BRPF1 P55201 1/20 0.34
GAA P10253 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
ACACB O00763 2/20 0.32
BCHE P06276 1/20 0.31
CNR2 P34972 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PTGDR Q13258 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814533 0.89 GPBAR1 (0.36) GPBAR1CYSLTR1FGFR1POLBSMN1; SMN2
SCHEMBL7818553 0.85 FGFR1 (0.48) FGFR1POLBBRD4BRPF1GAA
SCHEMBL7812496 0.79 MAPT (0.55) FGFR1MAPTHSD17B10MEN1KMT2A
SCHEMBL3652546 0.77 TDP1 (0.44) FGFR1POLBSMN1; SMN2MAPTHSD17B10
SCHEMBL7812089 0.77 FGFR1 (0.50) GPBAR1CYSLTR1FGFR1SMN1; SMN2MAPT
SCHEMBL7805417 0.73 BRD4 (0.47) FGFR1POLBBRD4BRPF1ACACB
SCHEMBL19121950 0.68 MAPT (0.41) GPBAR1CYSLTR1POLBMAPTHSD17B10
SCHEMBL122883 0.68 ACACB (0.45) GPBAR1CYSLTR1POLBMAPTHDAC1
SCHEMBL7814303 0.67 MAPT (0.48) SMN1; SMN2MAPTHSD17B10MEN1KMT2A
SCHEMBL4343247 0.67 NOS3 (0.44) FGFR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed